{"ticker": {"uuid": "f0f9c6d8-5f8d-4050-b04e-15967b5e6fe8", "symbol": "BIOV", "name": "BioVersys AG", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "BioVersys publishes BV100 phase 1 data, advances phase 3 trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOREFicy1CdUwzeGVqTUJLOXU4MkozNGI1N2xQcG9JRnl5emJfVzhxYmVWZ2NpRWdSdG1zdlVhRm9LeGQyWTN0QXZyWE9LeW93SjhUUmY4VjFiMTZyQXY2alJiN0tRdXZFcUFNZmc1dkY0QlQ3OFBPSEk3VU0xVlhEbWx5WEdzYUxjRThKbWN5ZEVNbzFMVEc1VF9wZFJVc2R2cHpwWmNFakxMNkRUNXAxd2c0S09vVmdNRXc?oc=5", "source_name": "Investing.com", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is BioVersys (VTX:BIOV) A Risky Investment?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-27T07:00:00+00:00", "published_display": "27 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "From Lab Bench to Bell Ring \u2013 Marc Gitzinger on BioVersys' road to IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOck05VG9TVFBJVlR1ZjlIdzBldDNkZGZTZW45X1YxUnA4SnJUSVI2MFV5TkdQazhfT0xHWS1TaXR5cmRHS2oyOU1aUDA0dGNqdW9PT3p4a2N4S05YdnBwbmtjemY1NkZ4Ynp4RHhPNTQzRzFsOGRJVU8wUEE2SDRka2FTM1VXcEpkeVdSbjVSVlVCR1dFd0QtNC03Q2Y?oc=5", "source_name": "Venturelab Swiss", "published_at": "2025-07-08T07:00:00+00:00", "published_display": "08 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioVersys AG: Target Price Consensus and Analysts Recommendations | BIOV | CH0210362643", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPbFN5djlES1NOVXd6OGN3MWhiNmtjWE5aYUVScEhhSVVUSGxwSnlPODZiQTRoeHV1d2RRVDk0cE8xUTlLN0VDb2RhdDVRa0NsaWlXc19LRUdMem51X3JFcVVjcFpUNmtGSlRGTm1Yck9PbnQ5WHpkWWRBUFRTRmpmaUdR?oc=5", "source_name": "marketscreener.com", "published_at": "2025-03-21T14:23:32+00:00", "published_display": "21 Mar 2025 14:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioVersys Opens IPO Season at SIX Swiss Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQdG1LSHQyUG1OeTFUTjd6UVV2QVZiQ0NyY1RPLXRhXy1OcTJaUjVsdFppeC0wWHNIN0xGQ0VzckdSekkxX0czRDIwRUlyVTU1NG9ORFZ6aXlHaUpTWG1CMzZOckYxbldSazNtTmQ5S3lnaXR4LU5zU2FtNHlVNWpxSkh5YWJsUi15cG52SF9R?oc=5", "source_name": "Startupticker.ch", "published_at": "2025-02-07T08:00:00+00:00", "published_display": "07 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "BioVersys publishes BV100 phase 1 data, advances phase 3 trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOREFicy1CdUwzeGVqTUJLOXU4MkozNGI1N2xQcG9JRnl5emJfVzhxYmVWZ2NpRWdSdG1zdlVhRm9LeGQyWTN0QXZyWE9LeW93SjhUUmY4VjFiMTZyQXY2alJiN0tRdXZFcUFNZmc1dkY0QlQ3OFBPSEk3VU0xVlhEbWx5WEdzYUxjRThKbWN5ZEVNbzFMVEc1VF9wZFJVc2R2cHpwWmNFakxMNkRUNXAxd2c0S09vVmdNRXc?oc=5", "source_name": "Investing.com", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is BioVersys (VTX:BIOV) A Risky Investment?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-27T07:00:00+00:00", "published_display": "27 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "From Lab Bench to Bell Ring \u2013 Marc Gitzinger on BioVersys' road to IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOck05VG9TVFBJVlR1ZjlIdzBldDNkZGZTZW45X1YxUnA4SnJUSVI2MFV5TkdQazhfT0xHWS1TaXR5cmRHS2oyOU1aUDA0dGNqdW9PT3p4a2N4S05YdnBwbmtjemY1NkZ4Ynp4RHhPNTQzRzFsOGRJVU8wUEE2SDRka2FTM1VXcEpkeVdSbjVSVlVCR1dFd0QtNC03Q2Y?oc=5", "source_name": "Venturelab Swiss", "published_at": "2025-07-08T07:00:00+00:00", "published_display": "08 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioVersys AG: Target Price Consensus and Analysts Recommendations | BIOV | CH0210362643", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPbFN5djlES1NOVXd6OGN3MWhiNmtjWE5aYUVScEhhSVVUSGxwSnlPODZiQTRoeHV1d2RRVDk0cE8xUTlLN0VDb2RhdDVRa0NsaWlXc19LRUdMem51X3JFcVVjcFpUNmtGSlRGTm1Yck9PbnQ5WHpkWWRBUFRTRmpmaUdR?oc=5", "source_name": "marketscreener.com", "published_at": "2025-03-21T14:23:32+00:00", "published_display": "21 Mar 2025 14:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioVersys Opens IPO Season at SIX Swiss Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQdG1LSHQyUG1OeTFUTjd6UVV2QVZiQ0NyY1RPLXRhXy1OcTJaUjVsdFppeC0wWHNIN0xGQ0VzckdSekkxX0czRDIwRUlyVTU1NG9ORFZ6aXlHaUpTWG1CMzZOckYxbldSazNtTmQ5S3lnaXR4LU5zU2FtNHlVNWpxSkh5YWJsUi15cG52SF9R?oc=5", "source_name": "Startupticker.ch", "published_at": "2025-02-07T08:00:00+00:00", "published_display": "07 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 67, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 27.5, "latest_week": "2026-07-10", "one_week_move": 1.9, "four_week_move": 5.0, "twelve_week_move": -5.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.486354, "market_dynamics_buy_signal": false, "relative_strength": -7.253124, "fair_value_gap": -6.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.6834, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.9% over one week, +5.0% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Investing.com", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Venturelab Swiss", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "Startupticker.ch", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+1.9% over one week, +5.0% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "BioVersys publishes BV100 phase 1 data, advances phase 3 trial"}], "updated_at": "2026-07-17T10:09:52.213721+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}